HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Suubi-Mhealth: A Mobile Health Intervention to Address Depression and Improve ART Adherence Among Youth Living With HIV (YLHIV) in Uganda

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overall goal of this study is to develop an mHealth intervention (Suubi-Mhealth) for use among Ugandan youth (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. This digital therapy intervention delivered via a mobile application, will utilize the core tenets of cognitive-behavioral therapy (CBT) found to improve depression and ART adherence.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 17
Healthy Volunteers: f
View:

• Ages 14-17 years

• HIV positive and aware of their status i.e., disclosed to

• Prescribed antiretroviral therapy

• Living within a family, including with extended family members (not in institutions)

• Health care providers who work with youth at participating clinics who agree to participate in the study.

Locations
United States
Missouri
Washington University in St. Louis
NOT_YET_RECRUITING
St Louis
Other Locations
Uganda
International Center for Child Health and Development (ICHAD)
RECRUITING
Masaka
Time Frame
Start Date: 2022-11-23
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 278
Treatments
Experimental: Suubi-Mhealth
Participants in this condition will receive the Suubi-Mhealth intervention delivered via a smart phone app.
Other: Waitlist Control
Participants in this condition will receive the Suubi-Mhealth intervention after the active treatment group. They will also receive a smart phone without the Suubi-Mhealth app at the same time as the intervention group.
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine
Collaborators: National Institute of Mental Health (NIMH)

This content was sourced from clinicaltrials.gov